With a Ph.D. in Molecular and Cellular Biology and over 10 years of hands-on lab experience, Brian brings real-world insight and deep knowledge to every matter.
Clients rely on Brian for tailored, forward-thinking advice that aligns with their business goals and the science behind their innovations. He works closely with early- and growth-stage companies, as well as leading universities, to build strong, defensible patent portfolios that support long-term success.
Brian has helped protect a wide range of technologies, including:
- Stem cells, recombinant proteins, and synthetic peptides
- Viral vectors, antibodies, and immunotherapies
- Biomarkers, biomaterials, nanoparticles, and microparticles
- Diagnostics, medical devices, and therapeutic methods
He assists clients at every stage of the IP process, from drafting and prosecuting U.S. and international patent applications to conducting freedom-to-operate and non-infringement analyses. He also advises investors and companies during due diligence for licensing deals and M&A transactions.
With a scientific background in immunogenetics, endocrinology, infectious disease, cardiology, and developmental biology, Brian helps clients protect what matters—and plan for what’s next.
